FDA approved Amgen’s aranesp for anemia associated with chemotherapy
On Jul. 22, 2002, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved Aranesp (darbepoetin…
Immunex Corp. was acquired by Amgen
On Jul. 16, 2002, Amgen completed it’s acquisition of Immunex Corporation for $16 billion in stock and net…
Biotechnology | Diagnostics | Disease | Life Science History | NIH | Non-Profit Research | Oncology | Therapeutics | Veterinary
The UC Davis Cancer Center received NCI designation
On Jul. 2, 2002, the University of California, Davis Comprehensive Cancer Center announced it had received National Cancer…
BOTOX(R) cosmetic (onabotulinumtoxinA) approved by the FDA
On Apr. 15, 2002, BOTOX(R) cosmetic (onabotulinumtoxinA), manufactured by Allergan, was approved by the Food and Drug Administration…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Therapeutics | Women's Health
Los Angeles Cancer Center Received $15 Million for Woman’s Health Center
On Mar. 26, 2005, The University of Southern California/Norris Comprehensive Cancer Center in Los Angeles announced a $15…
Stanford researchers became the first to use RNAi to switch off genes in mice
In 2002, Stanford researchers became the first to use RNAi to switch off genes in mice.
Stanford researchers became the first to use gene expression profiling to predict cancer outcomes
In 2002, Stanford researchers became the first to use gene expression profiling to predict cancer outcomes. The research…
The banteng, an endangered species, was cloned for the first time
In 2002, the banteng, an endangered species, was cloned for the first time. Bantengs, or Bali cattle (Bos…
The Nevada Cancer Institute was founded
In 2002, the Nevada Cancer Institute (NVCI), founded in 2002 and located in Summerlin, was a non-profit organization…
The acquisition of Immunex by Amgen for $16 billion was announced
On Dec. 17, 2001, the acquisition of Immunex by Amgen was announced for $16 billion in stock and…
Stanford researchers identified a novel gene family involved in asthma
On Nov. 19, 2001, researchers at Lucile Packard Children’s Hospital at Stanford announced they had identified a novel…
Genentech drug Cathflo Activase (alteplase) was approved
On Sept. 13, 2001, the Food and Drug Administration (FDA) announced it had approved Genentech’s request for it’s…
Biotechnology | FDA | HIV | Life Science News | Therapeutics
Genentech drug Valcyte (valganciclovir hydrochloride) was approved
On Mar. 29, 2001, the Food and Drug Administration (FDA) announced it had approved Genentech’s drug Valcyte (valganciclovir…
Livermore National Lab announced partnership with BioLuminate to develop ‘Smart Probe’ for breast cancer detection
On Jan. 10, 2001, Livermore National Laboratory announced a partnership with BioLuminate to develop ‘Smart Probe’ tool for…
Moores Cancer Center at UC San Diego achieved NCI designated comprehensive cancer center status
In 1978, Moores Cancer Center (MCC) at UC San Diego achieved National Cancer Institute (NCI) designated comprehensive cancer…
Compulsive shopping research at Stanford seeks to treat mysterious disorder
On Dec. 16, 2002, researchers at Stanford University Medical Center announced they were continuing a multi-year clinical trial…
Pathogenesis was acquired by Chiron for $660 million
On Sept. 22, 2000, Pathogenesis was acquired by Emeryville, California-based Chiron for $660 million or $38.50 per share….
Stanford researchers discovered hereditary arthritis gene
On Jul. 11, 2000, Stanford researchers announced they had identified a substance commonly added to toothpaste to prevent…
Genentech drug TNKase (tenecteplase) was approved
On June 2, 2000, the U.S. Food and Drug Administration announced it had approved Genentech’s drug TNKaseﾮ (tenecteplase)….
Stanford researchers solved the structure of the RNA polymerase protein
On Apr. 24, 2000, Stanford researchers announced they have solved the structure of the RNA polymerase protein, one…
The Norris Foundation committed $15 million toward construction of the Harlyne J Norris Research Tower
On Jan. 10, 2012, the Norris Foundation made a $15 million commitment toward construction of the Harlyne J….
The Stanford Hospital Center for Clinical Sciences Research building opened
In 2000, the Center for Clinical Sciences Research building opened, and is an example of a fully integrated…
QB 3 was founded as the University of California’s hub for innovation and entrepreneurship in life science
In 2000, QB3 founded as the University of California’s hub for innovation and entrepreneurship in life science, with…
Stanford researchers first used gene expression profiling to distinguish cancer sub-types
In 2000, Stanford researchers led by Ash Alizadeh announced they had used gene expression profiling to identify two…
The University of California, Riverside Center for Nanoscale Science and Engineering was established
In 2000, the University of California, Riverside Center for Nanoscale Science and Engineering was established to capitalize on…
FDA approved Targretin to treat certain T-cell lymphomas
On Dec. 29, 1999, the U.S. Food and Drug Administration (FDA) approved Bexarotene (Targretin) to treat cutaneous T-cell…
University of Washington announced the departure of Leroy Hood to establish a new instutute
On Dec. 13, 1999, the University of Washington (UW) announced that Dr. Leroy Hood, chair of the Department…
The Buck Institute for Research on Aging opened its doors
On Sept. 30, 1999, the Buck Institute for Research on Aging, named for Marin County philanthropists Leonard and…
Stanford researchers discovered a genetic mutation that causes narcolepsy
On Aug. 11, 1999, researchers led by Stanford’s Emmanuel Mignot, MD, PhD, associate professor of psychiatry, used a…
Gilead Sciences and NeXstar Pharmaceuticals announced completion of their merger
On Jul. 29, 1999, Gilead Sciences and NeXstar Pharmaceuticals announced the closing of their agreement whereby Gilead acquired…